ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0944

Inconsistent Family Planning Documentation in Women with Interstitial Pneumonia with Autoimmune Features (IPAF)

Elena Joerns1, Brooke Mills2, Una Makris3, Traci Adams1 and Bonnie Bermas1, 1UT Southwestern, Dallas, TX, 2UT Southwestern Medical Center, Fort Worth, TX, 3UT Southwestern Medical Center and Dallas VA, Dallas, TX

Meeting: ACR Convergence 2022

Keywords: education, patient, pulmonary, quality of care, Women's health

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2022

Title: Reproductive Issues in Rheumatic Disorders Poster

Session Type: Poster Session B

Session Time: 9:00AM-10:30AM

Background/Purpose: Family planning discussions improve pregnancy outcomes in women with interstitial lung disease (ILD). Women with interstitial pneumonia with autoimmune features (IPAF), a subset of ILD, are at risk for pregnancy complications. The objective of this study was to evaluate the documentation of family planning discussions with IPAF patients of childbearing age by pulmonary and rheumatology providers at an academic medical center.

Methods: We conducted a retrospective chart review of pulmonary and rheumatology encounters in reproductive aged women with IPAF to evaluate documentation of family planning discussions. We employed non-parametric measures of association to evaluate the relationship between patient characteristics and the presence of family planning discussion documentation by providers.

Results: Thirty one women met IPAF classification and were £50 years of age at initial ILD clinic visit. Twenty-five (83%) of these women had risk factors for adverse pregnancy outcomes. Ten women (33%) had a discussion of family planning or record of contraceptive use during any visit with their pulmonary provider. Out of the 21 patients who also saw a rheumatology provider, 12 (57%) women had a record of discussion of family planning or contraceptive use during any visit with their rheumatology provider.

Conclusion: Neither pulmonary nor rheumatology providers consistently discussed family planning with reproductive aged women with IPAF. There was a non-statistically significant trend for rheumatology providers to discuss reproductive issues with IPAF patients more frequently than pulmonary providers. Efforts should focus on educating providers about the need for family planning discussions in women with IPAF of childbearing age.

Supporting image 1

Figure 1: Reproductive counseling documentation in female patients with IPAF of child-bearing
age, by specialty


Disclosures: E. Joerns, Pfizer, Inc; B. Mills, None; U. Makris, None; T. Adams, None; B. Bermas, Bristol-Myers Squibb(BMS), Novartis.

To cite this abstract in AMA style:

Joerns E, Mills B, Makris U, Adams T, Bermas B. Inconsistent Family Planning Documentation in Women with Interstitial Pneumonia with Autoimmune Features (IPAF) [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/inconsistent-family-planning-documentation-in-women-with-interstitial-pneumonia-with-autoimmune-features-ipaf/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/inconsistent-family-planning-documentation-in-women-with-interstitial-pneumonia-with-autoimmune-features-ipaf/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology